Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research

Institute of Immunology, University of Oslo, Rikshospitalet University Hospital N-0027 Oslo, Norway. bjarne.bogen@labmed.uio.no Multiple myeloma (MM) remains a difficult-to-cure cancer and less than 20% of patients achieve long-term survival irrespective of the treatment delivered, including high-do...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Haematologica (Roma) 2006-07, Vol.91 (7), p.941-948
Hauptverfasser:	Bogen, B, Ruffini, PA, Corthay, A, Fredriksen, AB, Froyland, M, Lundin, K, Rosjo, E, Thompson, K, Massaia, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens, Neoplasm Humans Immunoglobulin Idiotypes - therapeutic use Immunotherapy - methods Multiple Myeloma - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!